Advances in Recombinant Protein Technology 2013
Tuesday, 19 November 2013 to Wednesday, 20 November 2013
Print Print
Presentation
Tue 19 November
20 November
DAY 1Main AuditoriumExhibition area
DAY 2
DAY 1Main AuditoriumExhibition area
DAY 2
8:00 8:00:
8:05: 8:05:
8:10: 8:10:
8:15: 8:15:
8:20: 8:20:
8:25: 8:25:
8:30: 8:30:
8:35: 8:35:
8:40: 8:40:
8:45: 8:45:
8:50: 8:50:
8:55: Registration 8:55:
9:00 9:00:
9:05: 9:05:
9:10: 9:10:
9:15: 9:15:
9:20: 9:20:
9:25: 9:25:
9:30: 9:30:
9:35: 9:35:
9:40: 9:40:
9:45: Introduction
09:45 (5 mins)

 9:45:
9:50: Evolving stable and well expressing GPCRs for structure determination and drug screening
09:50 (40 mins)
Andreas Plueckthun, University of Zurich  
Introduction
09:50 (10 mins)

 9:50:
9:55: 9:55:
10:00 Evolving stable and well expressing GPCRs for structure determination and drug screening
09:50 (40 mins)

 10:00
10:05 10:05
10:10 10:10
10:15 10:15
10:20 10:20
10:25 10:25
10:30 Understanding the yeast host response to recombinant (membrane) protein production
10:30 (25 mins)
Roslyn Bill, Aston University  
 10:30
10:35 10:35
10:40 10:40
10:45 10:45
10:50 10:50
10:55 Novel protein tools for the synthetic biologist: a CRISPr TALe of genome engineering
10:55 (25 mins)
Axel Trefzer, Life Technologies  
 10:55
11:00 11:00
11:05 11:05
11:10 11:10
11:15 11:15
11:20 Coffee Break 11:20
11:25 11:25
11:30 11:30
11:35 11:35
11:40 11:40
11:45 11:45
11:50 Novel tuneable gene expression systems based on orthogonal riboswitches
11:50 (25 mins)
Neil Dixon, University of Manchester  
 11:50
11:55 11:55
12:00 12:00
12:05 12:05
12:10 12:10
12:15 Utilizing Chinese Hamster Ovary Cell Population Heterogeneity for the Isolation of New Host Cell Lines for Recombinant Protein Production
12:15 (25 mins)
Peter O'Callaghan, Lonza  
 12:15
12:20 12:20
12:25 12:25
12:30 12:30
12:35 12:35
12:40 Simplified purification of secreted histidine-tagged proteins
12:40 (20 mins)
Marianne Carlsson, GE Healthcare  
 12:40
12:45 12:45
12:50 12:50
12:55 12:55
1:00 Lunch, Exhibitor and Poster Viewing 1:00:
1:05: 1:05:
1:10: 1:10:
1:15: 1:15:
1:20: 1:20:
1:25: 1:25:
1:30: 1:30:
1:35: 1:35:
1:40: 1:40:
1:45: 1:45:
1:50: 1:50:
1:55: 1:55:
2:00 2:00:
2:05: 2:05:
2:10: 2:10:
2:15: CHO genome engineering to decrease transcriptional and protein processing bottlenecks
14:15 (40 mins)
Nicolas Mermod, University of Lausanne   
 2:15:
2:20: 2:20:
2:25: 2:25:
2:30: 2:30:
2:35: 2:35:
2:40: 2:40:
2:45: 2:45:
2:50: 2:50:
2:55: Strategies to achieve gram per liter protein yields by mammalian transient expression
14:55 (25 mins)
Henry Chiou, Life Technologies  
 2:55:
3:00 3:00:
3:05: 3:05:
3:10: 3:10:
3:15: 3:15:
3:20: Development of a CHO-based cell line for high titre, scalable, transient gene expression
15:20 (25 mins)
Jessica Stevenson, MedImmune  
 3:20:
3:25: 3:25:
3:30: 3:30:
3:35: 3:35:
3:40: 3:40:
3:45: Coffee Break 3:45:
3:50: 3:50:
3:55: 3:55:
4:00 4:00:
4:05: 4:05:
4:10: 4:10:
4:15: Development and optimisation of a suspension CHO-EBNA transient gene expression system
16:15 (25 mins)
Jennifer Halsall, AstraZeneca AB  
 4:15:
4:20: 4:20:
4:25: 4:25:
4:30: 4:30:
4:35: 4:35:
4:40: Streamlining the glutamine synthetase-based protein expression system
16:40 (25 mins)
Ray Owens, OPPF, Oxford  
 4:40:
4:45: 4:45:
4:50: 4:50:
4:55: 4:55:
5:00 5:00:
5:05: Maximizing recombinant protein expression through systematic gene design
17:05 (40 mins)
Claes Gustafsson, DNA2.0  
 5:05:
5:10: 5:10:
5:15: 5:15:
5:20: 5:20:
5:25: 5:25:
5:30: 5:30:
5:35: 5:35:
5:40: 5:40:
5:45: 5:45:
5:50: 5:50:
5:55: 5:55:
6:00 6:00: